Koen A. Marijt

1.5k total citations
13 papers, 672 citations indexed

About

Koen A. Marijt is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Koen A. Marijt has authored 13 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Koen A. Marijt's work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (7 papers). Koen A. Marijt is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (7 papers). Koen A. Marijt collaborates with scholars based in Netherlands, United States and Germany. Koen A. Marijt's co-authors include Thorbald van Hall, Sjoerd H. van der Burg, Marjolein Sluijter, Elien M. Doorduijn, Marieke F. Fransen, Jan Willem Kleinovink, Mark J.A. Schoonderwoerd, Ferry Ossendorp, Pascale André and Nadine van Montfoort and has published in prestigious journals such as Cell, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Koen A. Marijt

13 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koen A. Marijt Netherlands 10 480 408 151 74 52 13 672
Jonathan J. Hodgins Canada 5 631 1.3× 530 1.3× 150 1.0× 55 0.7× 55 1.1× 7 803
Houssein Abdul Sater United States 11 298 0.6× 373 0.9× 122 0.8× 81 1.1× 41 0.8× 33 513
Alexander Martens Germany 14 530 1.1× 503 1.2× 181 1.2× 46 0.6× 43 0.8× 22 787
Alison M. McDonnell Australia 16 415 0.9× 432 1.1× 85 0.6× 130 1.8× 35 0.7× 25 650
Ryan Montler United States 8 659 1.4× 628 1.5× 119 0.8× 47 0.6× 33 0.6× 10 862
Ilia N. Buhtoiarov United States 15 614 1.3× 409 1.0× 164 1.1× 36 0.5× 30 0.6× 30 812
Arnold Baars Netherlands 11 356 0.7× 363 0.9× 189 1.3× 47 0.6× 53 1.0× 23 592
Alfons JM van den Eertwegh Netherlands 7 381 0.8× 420 1.0× 96 0.6× 107 1.4× 22 0.4× 8 546
Dmitrij Ostroumov Germany 5 294 0.6× 337 0.8× 137 0.9× 60 0.8× 63 1.2× 6 526
Mohamed ElTanbouly United States 11 477 1.0× 296 0.7× 121 0.8× 58 0.8× 19 0.4× 15 675

Countries citing papers authored by Koen A. Marijt

Since Specialization
Citations

This map shows the geographic impact of Koen A. Marijt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen A. Marijt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen A. Marijt more than expected).

Fields of papers citing papers by Koen A. Marijt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen A. Marijt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen A. Marijt. The network helps show where Koen A. Marijt may publish in the future.

Co-authorship network of co-authors of Koen A. Marijt

This figure shows the co-authorship network connecting the top 25 collaborators of Koen A. Marijt. A scholar is included among the top collaborators of Koen A. Marijt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koen A. Marijt. Koen A. Marijt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Rostamian, Somayeh, Saskia le Cessie, Koen A. Marijt, et al.. (2022). Association of cognitive function with increased risk of cancer death and all-cause mortality: Longitudinal analysis, systematic review, and meta-analysis of prospective observational studies. PLoS ONE. 17(1). e0261826–e0261826. 9 indexed citations
2.
Marijt, Koen A., et al.. (2021). Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement. Cancer Immunology Immunotherapy. 71(2). 289–300. 7 indexed citations
3.
Garrido, Greta, Brett Schrand, Agata Levay, et al.. (2020). Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors. Cancer Immunology Research. 8(7). 856–868. 8 indexed citations
4.
Marijt, Koen A. & Thorbald van Hall. (2020). To TAP or not to TAP: alternative peptides for immunotherapy of cancer. Current Opinion in Immunology. 64. 15–19. 15 indexed citations
5.
Garrido, Greta, Brett Schrand, Ailem Rabasa, et al.. (2019). Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity. Nature Communications. 10(1). 3773–3773. 50 indexed citations
6.
Marijt, Koen A., Sjoerd H. van der Burg, & Thorbald van Hall. (2019). TEIPP peptides: exploration of unTAPped cancer antigens. OncoImmunology. 8(8). 1599639–1599639. 8 indexed citations
7.
Marijt, Koen A., Marjolein Sluijter, Sofie H. Tolmeijer, et al.. (2019). Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling. Journal for ImmunoTherapy of Cancer. 7(1). 152–152. 66 indexed citations
8.
Marijt, Koen A., Els M.E. Verdegaal, Michel G.D. Kester, et al.. (2018). Identification of non-mutated neoantigens presented by TAP-deficient tumors. The Journal of Experimental Medicine. 215(9). 2325–2337. 53 indexed citations
9.
Marijt, Koen A., Elien M. Doorduijn, & Thorbald van Hall. (2018). TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class Ilow cancers. Molecular Immunology. 113. 43–49. 36 indexed citations
10.
Montfoort, Nadine van, Michael Korrer, Marjolein Sluijter, et al.. (2018). NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines. Cell. 175(7). 1744–1755.e15. 241 indexed citations
11.
Doorduijn, Elien M., Marjolein Sluijter, Koen A. Marijt, et al.. (2017). T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy. OncoImmunology. 7(3). e1382793–e1382793. 20 indexed citations
12.
Kleinovink, Jan Willem, Koen A. Marijt, Mark J.A. Schoonderwoerd, et al.. (2017). PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy. OncoImmunology. 6(4). e1294299–e1294299. 110 indexed citations
13.
Kroon, Jan, Martin Puhr, Jeroen T. Buijs, et al.. (2015). Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer. Endocrine Related Cancer. 23(1). 35–45. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026